EBSCO Research | Research

Current News

Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymp...

Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymp... 2024-01-19 04:00:00

Time trends and modifiable factors of COVID-19 contact tracing coverage, Geneva, Switzerland, June 2020 to February 2022

Time trends and modifiable factors of COVID-19 contact tracing coverage, Geneva, Switzerland, June 2020 to February 2022 2024-01-19 04:00:00

Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?

Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis? 2024-01-19 04:00:00

The Trend of Arrhythmias in Patients With COVID-19: A Complication or Late Manifestation?

The Trend of Arrhythmias in Patients With COVID-19: A Complication or Late Manifestation? 2024-01-19 04:00:00

Immunological and virological triggers of type 1 diabetes: insights and implications

Immunological and virological triggers of type 1 diabetes: insights and implications 2024-01-19 04:00:00